Description
Recombinant monoclonal antibody to CA125. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma OC125-3.11.
Target
CA125
Target Alias Names
CA-125, CA 125, MUC16, MUC-16, Mucin-16, Ovarian cancer-related tumor marker CA125, Ovarian carcinoma antigen CA125, VK8, VK-8
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression